135 related articles for article (PubMed ID: 492449)
1. Effect of Met-enkephalin and (D-Met2,Pro5)-enkephalinamide on the adenylate cyclase activity of rat brain.
Wollemann M; Szebeni A; Bajusz S; Gráf L
Neurochem Res; 1979 Oct; 4(5):627-31. PubMed ID: 492449
[TBL] [Abstract][Full Text] [Related]
2. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
Jhamandas K; Sutak M
Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
[TBL] [Abstract][Full Text] [Related]
3. Interaction of morphine, etorphine and enkephalins with dopamine-stimulated adenylate cyclase of monkey amygdala.
Walczak SA; Wilkening D; Makman MH
Brain Res; 1979 Jan; 160(1):105-16. PubMed ID: 214205
[TBL] [Abstract][Full Text] [Related]
4. Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.
Miglécz E; Székely JI; Dunai-Kovács Z
Psychopharmacology (Berl); 1979 Mar; 62(1):29-34. PubMed ID: 108745
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of a synethetic enkephalin analogue (D-Met2,Pro5)-enkephalinamide on the hypothalamus-pituitary--testis function in rats.
Vermes I; Szontágh L; Telegdy G
Neurosci Lett; 1979 Feb; 11(2):201-4. PubMed ID: 379712
[TBL] [Abstract][Full Text] [Related]
6. (D-Met2,Pro5)-enkephalinamide-induced blockade of ovulation and its reversal by naloxone in the rat.
Köves K; Marton J; Molnár J; Halász B
Neuroendocrinology; 1981 Feb; 32(2):82-6. PubMed ID: 6782500
[TBL] [Abstract][Full Text] [Related]
7. In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog.
Székely JI; Dunai-Kovács Z; Miglécz E; Rónai AZ; Bajusz S
J Pharmacol Exp Ther; 1978 Dec; 207(3):878-83. PubMed ID: 731437
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the dopamine stimulated adenylate cyclase in the pedal ganglia of Mytilus edulis: interactions with etorphine, beta-endorphin, DALA, and methionine enkephalin.
Stefano GB; Catapane EJ; Kream RM
Cell Mol Neurobiol; 1981 Mar; 1(1):57-68. PubMed ID: 6286125
[TBL] [Abstract][Full Text] [Related]
9. Demonstration and characterization of opiate inhibition of the striatal adenylate cyclase.
Law PY; Wu J; Koehler JE; Loh HH
J Neurochem; 1981 May; 36(5):1834-46. PubMed ID: 7241139
[TBL] [Abstract][Full Text] [Related]
10. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
Olianas MC; Onali P
Mol Pharmacol; 1992 Jul; 42(1):109-15. PubMed ID: 1321951
[TBL] [Abstract][Full Text] [Related]
11. Effect of the administration of (d-Ala) 2methionine-enkephalin on the serotonin metabolism in rat brain.
Algeri A; Consolazione A; Calderini G; Achilli G; Canas EP; Garattini S
Experientia; 1978 Nov; 34(11):1488-9. PubMed ID: 720481
[TBL] [Abstract][Full Text] [Related]
12. Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study.
Nicoll RA; Siggins GR; Ling N; Bloom FE; Guillemin R
Proc Natl Acad Sci U S A; 1977 Jun; 74(6):2584-8. PubMed ID: 267951
[TBL] [Abstract][Full Text] [Related]
13. Increase of plasma ACTH in the rat following the administration of D-met2-pro5-enkephalinamide.
Reina RA; Costa G; Scoto GM; Spadaro C; Spampinato S; Ferri S
Pharmacol Res Commun; 1980 May; 12(5):479-82. PubMed ID: 6108573
[No Abstract] [Full Text] [Related]
14. Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice.
Ueda H; Amano H; Shiomi H; Takagi H
Eur J Pharmacol; 1979 Jun; 56(3):265-8. PubMed ID: 582583
[TBL] [Abstract][Full Text] [Related]
15. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
Nijssen PC; Sexton T; Childers SR
J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327
[TBL] [Abstract][Full Text] [Related]
16. Spreading depression induced by microinjection of enkephalins into the hippocampus and neocortex.
Sprick U; Oitzl MS; Ornstein K; Huston JP
Brain Res; 1981 Apr; 210(1-2):243-52. PubMed ID: 7225810
[TBL] [Abstract][Full Text] [Related]
17. Respiratory effects of beta-endorphin, D-Ala2-met-enkephalinamide, and Met-enkephalin injected into the lateral ventricle and the pontomedullary subarachnoid space.
Flórez J; Mediavilla A; Pazos A
Brain Res; 1980 Oct; 199(1):197-206. PubMed ID: 7407621
[TBL] [Abstract][Full Text] [Related]
18. Behavioral activating effects of opiates and opioid peptides.
Browne RG; Segal DS
Biol Psychiatry; 1980 Feb; 15(1):77-86. PubMed ID: 6101965
[TBL] [Abstract][Full Text] [Related]
19. The in vitro pharmacology of D-Met2,Pro5-enkephalinamide.
Rónai AZ; Berzétei IP; Bajusz S; Székely JI
J Pharm Pharmacol; 1981 Aug; 33(8):534-5. PubMed ID: 6115930
[No Abstract] [Full Text] [Related]
20. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
